Penumbra Correlations

PEN Stock  USD 280.07  1.33  0.48%   
The current 90-days correlation between Penumbra and Globus Medical is 0.09 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Penumbra moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Penumbra moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Penumbra. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in banks.
To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.

Moving together with Penumbra Stock

  0.61BRK-A Berkshire HathawayPairCorr

Moving against Penumbra Stock

  0.51UEC Uranium Energy CorpPairCorr
  0.44PATH Uipath IncPairCorr
  0.41CYCC CYCC Old Symbol ChangePairCorr
  0.34PLG Platinum Group MetalsPairCorr
  0.63MSFT Microsoft Aggressive PushPairCorr
  0.42CAT CaterpillarPairCorr
  0.41GE GE AerospacePairCorr
  0.36IBM International BusinessPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CRLBIO
BAXDVA
HSICGMED
HQYGMED
HSICALGN
BIOGMED
  

High negative correlations

HIMSALGN
HIMSGMED
BAXGMED
BAXHQY
HSICHIMS
DVAHQY

Risk-Adjusted Indicators

There is a big difference between Penumbra Stock performing well and Penumbra Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Penumbra's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.